|
CN112245403A
|
|
Phosphodiesterase-4 inhibitor and oral solid composition thereof
|
|
CN111039891A
|
|
Method for synthesizing febuxostat and intermediate thereof
|
|
CN111072591A
|
|
Febuxostat, intermediate and synthesis thereof
|
|
CN107648195A
|
|
Stable Febustat capsule medicine composition
|
|
CN107669656A
|
|
Febustat capsule medicine composition and preparation method
|
|
CN106389371A
|
|
Tofacitinib citrate pharmaceutical composition
|
|
CN107616969A
|
|
The pyrrole Lun Panai troche medical compositions being disintegrated rapidly
|
|
CN106370757A
|
|
Tofacitinib citrate tablet pharmaceutical composition and quality control method
|
|
CN106389367A
|
|
Perampanel coated tablet pharmaceutical composition
|
|
CN104592105A
|
|
Regorafenib and manufacture method thereof
|
|
CN104546776A
|
|
Regorafenib tablet pharmaceutical composition and preparation method thereof
|
|
CN104546795A
|
|
Acarbose capsule and preparation method thereof
|
|
CN104523653A
|
|
Acarbose capsule pharmaceutical composition
|
|
CN104173313A
|
|
Rivaroxaban troche pharmaceutical composition
|
|
CN104130248A
|
|
Preparation method of rivaroxaban
|
|
CN103989812A
|
|
Cure-all five-spice paste as well as preparation method and use thereof
|
|
CN103977134A
|
|
All-heal aromatic cream
|
|
CN103467412A
|
|
Drug chemical compound for gout
|
|
CN103396378A
|
|
Stable febuxostat crystal
|
|
CN103251594A
|
|
Repaglinide/metformin combo tablet
|
